Toxicological evaluation of exosomes derived from human adipose tissue-derived mesenchymal stem/stromal cells
- 22 May 2020
- journal article
- research article
- Published by Elsevier BV in Regulatory Toxicology and Pharmacology
- Vol. 115, 104686
- https://doi.org/10.1016/j.yrtph.2020.104686
Abstract
No abstract availableKeywords
Funding Information
- ExoCoBio Inc
- Korean MOTIE R&D Program of Development of Material & Component Technology (#10079925)
This publication has 29 references indexed in Scilit:
- Exosomes: the future of biomarkers in medicineBiomarkers in Medicine, 2013
- Improvement of the Bovine Corneal Opacity and Permeability (BCOP) assay as an in vitro alternative to the Draize rabbit eye irritation testToxicology in Vitro, 2013
- Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?Cellular and Molecular Life Sciences, 2013
- Mesenchymal stem cell: An efficient mass producer of exosomes for drug deliveryAdvanced Drug Delivery Reviews, 2013
- A catch-up validation study on reconstructed human epidermis (SkinEthic™ RHE) for full replacement of the Draize skin irritation testToxicology in Vitro, 2010
- Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current ViewsThe International Journal of Cell Cloning, 2007
- Oral acute toxic class method: A successful alternative to the oral LD50 testRegulatory Toxicology and Pharmacology, 2005
- The local lymph node assay: developments and applicationsToxicology, 1994
- Production of basement membrane components by a reconstructed epidermis cultured in the absence of serum and dermal factorsBritish Journal of Dermatology, 1993
- Terminal Epidermal Differentiation of Human Keratinocytes Grown in Chemically Defined Medium on Inert Filter Substrates at the Air-Liquid InterfaceJournal of Investigative Dermatology, 1990